Jiri Petera
Charles University in Prague
32 Papers
163 Citations
Jiri Petera is an academic researcher from Charles University in Prague. The author has contributed to research in topics: Radiation therapy & Brachytherapy. The author has an hindex of 9, co-authored 32 publications.
Chat about Author
Papers
Distant Metastasis in Colorectal Cancer Patients-Do We Have New Predicting Clinicopathological and Molecular Biomarkers? A Comprehensive Review.
Stanislav Filip,Veronika Vymetalkova,Veronika Vymetalkova,Veronika Vymetalkova,Jiri Petera,Ludmila Vodickova,Ludmila Vodickova,Ludmila Vodickova,Ondrej Kubecek,Stanislav John,Filip Cecka,Marketa Krupova,Monika Manethova,Klara Cervena,Klara Cervena,Pavel Vodicka,Pavel Vodicka,Pavel Vodicka +17 more
TL;DR: In this paper, a review of possible molecular and clinicopathological biomarkers that may provide prognostic and predictive information for patients with distant metastasis is presented, including sideness of the tumor, molecular profile and epigenetic characteristics of the primary tumor and arising metastatic CRC, and early markers reflecting cancer cell resistance in mCRC.
54
Prognostic impact of hemoglobin level prior to radiotherapy on survival in patients with glioblastoma.
Karel Odrazka,Jiri Petera,Tereza Kohlova,Martin Dolezel,Miloslava Vaculikova,Milan Zouhar,Václav Málek,Vladimir Hobza,Ivan Latr,Stanislav Nemecek,Miroslav Šercl,Pavel Ryska,Milan Bláha,Eva Cermakova +13 more
TL;DR: It is indicated that lower Hb level prior to radiotherapy for glioblastoma can adversely influence prognosis, and this finding deserves further evaluation.
29
Prognostic Significance of Human Papillomavirus (HPV) Status and Expression of Selected Markers (HER2/neu, EGFR, VEGF, CD34, p63, p53 and Ki67/MIB-1) on Outcome After (Chemo-) Radiotherapy in Patients with Squamous Cell Carcinoma of Uterine Cervix
Milan Vošmik,Jan Laco,Igor Sirák,Martin Beranek,Eva Hovorkova,Hana Vošmiková,Monika Drastíková,Miroslav Hodek,Zdenek Zoul,Karel Odrazka,Jiri Petera +10 more
TL;DR: The presented study did not confirm any apparently significant association of the suggested markers with prognosis of SCCC in patients treated with (chemo-) radiotherapy in patients treating with radiotherapy with a curative intent.
27
Technological advances in radiotherapy for esophageal cancer.
Milan Vošmik,Jiri Petera,Igor Sirák,Miroslav Hodek,Petr Paluska,Jiri Dolezal,Marcela Kopáčová +6 more
TL;DR: Radiotherapy with concurrent chemotherapy and surgery represent the main treatment modalities in esophageal cancer, and reduction of radiotherapy-related toxicity is fundamental to the improvement of clinical results.
26
Utilization of cone-beam CT for offline evaluation of target volume coverage during prostate image-guided radiotherapy based on bony anatomy alignment.
Petr Paluska,Josef Hanus,Jana Sefrova,Lucie Rouskova,Jakub Grepl,Jan Jansa,Linda Kašaová,Miroslav Hodek,Milan Zouhar,Milan Vošmik,Jiri Petera +10 more
TL;DR: Sufficient dose coverage of target volumes was not achieved for all patients and reducing of safety margin is not acceptable, meaning initial rectal and bladder volumes cannot be considered representative for subsequent treatment.
23